• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

特拉匹韦双环吡咯烷中间体的合成新工艺

石予白, 王艳芳, 马少华

石予白, 王艳芳, 马少华. 特拉匹韦双环吡咯烷中间体的合成新工艺[J]. 中国药科大学学报, 2014, 45(5): 529-534. DOI: 10.11665/j.issn.1000-5048.20140504
引用本文: 石予白, 王艳芳, 马少华. 特拉匹韦双环吡咯烷中间体的合成新工艺[J]. 中国药科大学学报, 2014, 45(5): 529-534. DOI: 10.11665/j.issn.1000-5048.20140504
SHI Yubai, WANG Yanfang, MA Shaohua. A new synthetic process of bicyclic pyrrolidine intermediate in telaprevir[J]. Journal of China Pharmaceutical University, 2014, 45(5): 529-534. DOI: 10.11665/j.issn.1000-5048.20140504
Citation: SHI Yubai, WANG Yanfang, MA Shaohua. A new synthetic process of bicyclic pyrrolidine intermediate in telaprevir[J]. Journal of China Pharmaceutical University, 2014, 45(5): 529-534. DOI: 10.11665/j.issn.1000-5048.20140504

特拉匹韦双环吡咯烷中间体的合成新工艺

基金项目: 宁波市自然科学基金资助项目(No.2013A610089)

A new synthetic process of bicyclic pyrrolidine intermediate in telaprevir

  • 摘要: 对特拉匹韦的双环吡咯烷中间体开展合成新工艺研究:以3-氮杂双环[3.3.0]辛烷盐酸盐( 9 )为起始原料,通过亚胺基氯代、碱性消除、磺酸化、氰化和酸性水解等一系列反应得到外消旋体(3αR,6αS)-八氢环戊二烯并[c]吡咯-1-羧酸盐酸盐( 4 )。游离化合物( 4 )后,通过对亚胺进行Boc保护、化学拆分、羧基的叔丁酯化、亚胺的脱保护、成草酸盐等反应制得目标产物(1S,3αR,6αS)-八氢环戊二烯并[c]吡咯-1-羧酸叔丁酯草酸盐( 1 ),总收率约26.4%。本合成路线操作简单,光学纯度易于控制,适于进行工业化放大生产。
    Abstract: This paper described a practical process for the preparation of bicyclic pyrrolidine intermediate of telaprevir. The racemate, (3αR, 6αS)-octahydro-cyclopenta[c]pyrrole-1-carboxylic acid hydrochloride( 4 )was synthesized from 3-azabicyclo[3. 3. 0]nonane hydrochloride( 9 ) via chlorination of an imine, basic elimination, sulfonation, cyanation, and acid hydrolysis. The target product, (1S, 3αR, 6αS)-octahydrocyclopenta[c]pyrrole-1-carboxylic-t-butylester oxalate( 1 )was synthesized in an overall yield of about 26. 4% from the free amino acid of compound 4 via Boc protection of the imino, chemical resolution, t-butyl esterification of the carboxyl group, imino deprotection, and formation of the oxalate salt. The convergent synthetic process of compound 1 highlights the ease of operation and high stereoselectivity, and thus should be applicable for large-scale production.
  • [1] Matthews SJ,Lancaster JW.Telaprevir:a hepatitis C NS3/4A protease inhibitor[J].Clin Ther,2012,34(9):1 857-1 882.
    [2] Ding HX,Liu KKC,Sakya SM,et al.Synthetic approaches to the 2011 new drugs[J].Bioorg Med Chem,2013,21(11):2 795-2 825.
    [3] Tanoury GJ,Chen M,Cochran JE,et al.Processes and intermediates:US,2010126881[P].2010-04-11.
    [4] Tanoury GJ,Chen M,Cochran JE.Processes and intermediates:US,2007022459[P].2007-02-22.
    [5] Berranger T,Demonchaux P.Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.1.0] -hexane compounds utilizing bisulfite intermediate:US,2008082508[P].2008-07-10.
计量
  • 文章访问数: 
  • HTML全文浏览量:  0
  • PDF下载量: 
  • 被引次数: 0
出版历程
  • 刊出日期:  2014-10-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭